Borish Center-Ophthalmic Rsrch is categorized under Medical Research in Bloomington, IN and active since 1995.
Borish Center-Ophthalmic Rsrch was established in 1995, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5417110 by the NAICS.
If you are seeking more information, feel free to contact Ann Elsner, Manager at the company’s single location by writing to 800 East Atwater Avenue, Bloomington, Indiana IN 47405 or by phoning (812) 855-4093. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Borish Center-Ophthalmic Rsrch |
| Contact Person: | Ann Elsner, Manager |
| Address: | 800 East Atwater Avenue, Bloomington, Indiana 47405 |
| Phone Number: | (812) 855-4093 |
| Website Address: | indiana.edu |
| Annual Revenue (USD): | Unknown |
| Founded: | 1995 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 5417110 |
| Share This Business: |
Borish Center-Ophthalmic Rsrch was started in 1995 to provide professional Medical Research under the SIC code 8733 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Ann Elsner, Manager for inquiries that concern Borish Center-Ophthalmic Rsrch by calling the company number (812) 855-4093, as your correspondence is most welcome. Additionally, the physical location of the single location of Borish Center-Ophthalmic Rsrch can be found at the coordinates 39.16306,-86.52264 as well as the street address 800 East Atwater Avenue in Bloomington, Indiana 47405.
For its online presence, you may visit Borish Center-Ophthalmic Rsrch’s website at indiana.edu and engage with its social media outlets through on Twitter and on Facebook.